Covered recipient · General Payments record
FRANCIS L WIEGMANN JR.
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$3,537.71
- Reported across 124 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $507.24 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $154.48 | 2 |
| GlaxoSmithKline, LLC. | $123.87 | 1 |
| Novo Nordisk AS | $92.12 | 5 |
| Amgen Inc. | $43.04 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $28.55 | 1 |
| JAZZ PHARMACEUTICALS INC. | $28.10 | 1 |
| ABBVIE INC. | $23.45 | 1 |
| Lilly USA, LLC | $13.63 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.45 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106335999 | CMS |
| Amgen Inc. | $21.08 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117414889 | CMS |
| Amgen Inc. | $21.96 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117414891 | CMS |
| Astellas Pharma US Inc | $32.48 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139315458 | CMS |
| Astellas Pharma US Inc | $122.00 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139379044 | CMS |
| GlaxoSmithKline, LLC. | $123.87 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115881278 | CMS |
| JAZZ PHARMACEUTICALS INC. | $28.10 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150229301 | CMS |
| Lilly USA, LLC | $13.63 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134982426 | CMS |
| Novartis Pharmaceuticals Corporation | $28.55 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087385134 | CMS |
| Novo Nordisk Inc | $20.93 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097264884 | CMS |
| Novo Nordisk Inc | $15.11 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097631812 | CMS |
| Novo Nordisk Inc | $20.42 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097140901 | CMS |
| Novo Nordisk Inc | $16.23 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097513951 | CMS |
| Novo Nordisk Inc | $19.43 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096639851 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.